研究证实临床无功能的或分泌促性腺素的垂体腺瘤内存在多巴胺受体,而多巴胺激动剂能抑制大多数这类垂体腺瘤释放促性腺素及其亚单位。为此作者对5例进行了治疗。病人和方法临床无功能的或分泌促性腺素或α-亚单位的垂体腺癌患者5例,其中2例为临床无功能的垂体腺癌,2例能分泌α-亚单位,1例为分泌促性腺素的垂体腺瘤。所有患者 Studies confirm the presence of dopamine receptors in clinically nonfunctional or gonadotrophin-secreting pituitary adenomas, whereas dopamine agonists inhibit the release of gonadotropins and their subunits in most of these pituitary adenomas. To this end the authors were treated in 5 cases. Patients and Methods There were 5 cases of pituitary adenocarcinoma with clinically non-functioning or secreting gonadotropin or α-subunit, 2 of whom were clinically non-functional pituitary adenocarcinoma, 2 of whom were capable of secreting α-subunit and 1 of whom were secretory Gonadotropin pituitary adenoma. All patients